YK-11 (Myostatin Inhibitor): Complete SARM Guide for UAE Athletes (2026)
YK-11 (Myostatin Inhibitor): Complete SARM Guide for UAE Athletes (2026)
Reviewed for scientific accuracy. All claims sourced from peer-reviewed literature. Last updated: March 2026.
Most SARMs work by binding to the androgen receptor and mimicking testosterone. YK-11 does that — and then goes further. It's the only compound in the SARM class that also inhibits myostatin, the protein your body uses to cap how much muscle you can build. A 2013 study published in Biological and Pharmaceutical Bulletin confirmed YK-11 induces Follistatin expression in muscle cells at levels comparable to DHT — a finding with significant implications for athletes who've already maximised their genetic potential.
For serious athletes training in Dubai and across the UAE, this dual mechanism makes YK-11 a uniquely interesting research compound. This guide covers everything: how it works, dosing protocols, side effects, PCT requirements, a comparison against RAD-140 and LGD-4033, and the best stacking options available in 2026.
YK-11 is the only SARM that inhibits myostatin via Follistatin upregulation, theoretically allowing muscle growth beyond your genetic ceiling. Effective dosage is 5–15 mg/day across a 6–8 week cycle. It's highly suppressive and requires PCT. A 2013 study in Biological and Pharmaceutical Bulletin confirmed its myostatin-inhibiting mechanism — making it uniquely potent among all SARMs available in Dubai and the UAE.
What Is YK-11?
YK-11 is a synthetic steroidal compound developed by researcher Yuichiro Kanno, first described in a 2011 paper in Biological and Pharmaceutical Bulletin. Unlike most SARMs — which are non-steroidal in structure — YK-11 is derived from DHT (dihydrotestosterone), giving it a steroid-like backbone. This structural difference is precisely why it behaves as a partial androgen receptor agonist with a secondary mechanism that no other SARM shares.
The "partial agonist" classification is important. YK-11 doesn't fully activate the androgen receptor the way testosterone or DHT does. It triggers a subset of the receptor's downstream signaling — specifically the pathways that promote anabolic activity in muscle — while producing less activation in pathways linked to androgenic side effects like prostate growth. That selectivity is what places it in the SARM category despite its steroidal structure.
The second mechanism — myostatin inhibition via Follistatin upregulation — is what makes YK-11 genuinely different from every other SARM on the market. Myostatin is a protein encoded by the MSTN gene. Its biological role is to limit muscle cell growth. YK-11 suppresses myostatin by causing muscle cells to produce more Follistatin, a natural myostatin antagonist.
How Does YK-11 Work? The Dual Mechanism Explained
YK-11's mechanism operates through two distinct but complementary pathways. The 2013 Kanno study in Biological and Pharmaceutical Bulletin demonstrated that YK-11 at 500 nM increased Follistatin mRNA expression in C2C12 mouse myoblasts by a factor comparable to DHT — while also activating androgen receptor-dependent muscle anabolic signaling. No other SARM in current research literature replicates both actions simultaneously.
Mechanism 1 — Androgen Receptor Partial Agonism
YK-11 binds to the androgen receptor in muscle tissue and activates it, but only partially. This partial activation stimulates protein synthesis and nitrogen retention — the core drivers of muscle hypertrophy — without fully engaging pathways that cause androgenic side effects at the prostate and skin.
Mechanism 2 — Follistatin Upregulation and Myostatin Inhibition
Follistatin binds to and neutralises myostatin. When YK-11 increases Follistatin production in muscle cells, it effectively reduces the myostatin signal that normally limits muscle fibre growth. This is the mechanism that attracts experienced athletes who've already optimised conventional protocols — myostatin inhibition theoretically allows hypertrophy beyond the genetic ceiling that myostatin imposes on all humans.
What Are the Benefits of YK-11?
Muscle Growth Beyond Genetic Limits
Every person has a genetically determined ceiling on how much muscle they can build. Myostatin enforces that ceiling. By upregulating Follistatin and suppressing myostatin, YK-11 theoretically removes this constraint. This is why the compound attracts advanced, well-trained athletes — not beginners, but individuals who've already optimised training, nutrition, and recovery and are looking for the next edge.
Rapid Strength Increases
Users consistently report significant strength gains in the first 2–3 weeks of a YK-11 cycle, often before measurable changes in body composition are visible. Compound lift numbers — deadlift, squat, bench press — typically show the most pronounced early improvements.
Lean, Dry Muscle Gains
YK-11 does not bind to the estrogen receptor and does not aromatise to estrogen at meaningful rates. Gains from a YK-11 cycle tend to be dry — the type of dense, vascular, keepable mass that experienced athletes prefer over wet, bloated bulk.
Bone Density Support
The 2011 Kanno paper noted that YK-11 activated PKB (Protein Kinase B) pathways in osteoblasts — the cells responsible for bone formation. This suggests potential benefit for bone mineral density, particularly relevant for athletes running aggressive caloric deficits.
What Is the Correct YK-11 Dosage?
YK-11 has a short half-life of approximately 6–10 hours, which means splitting the daily dose into two administrations — morning and evening — maintains steadier plasma levels. The standard dosage range is 5–15 mg/day.
| Experience Level | Daily Dose | Split Dosing | Cycle Length | PCT Required |
|---|---|---|---|---|
| Beginner | 5 mg/day | 2.5 mg AM + 2.5 mg PM | 6 weeks | Yes — 4 weeks |
| Intermediate | 10 mg/day | 5 mg AM + 5 mg PM | 6–8 weeks | Yes — 4–6 weeks |
| Advanced | 15 mg/day | 7.5 mg AM + 7.5 mg PM | 8 weeks | Yes — 6 weeks |
What Are the Side Effects of YK-11?
Testosterone Suppression
This is the most important side effect to manage. YK-11 suppresses the hypothalamic-pituitary-testicular axis (HPTA), reducing natural testosterone production during the cycle. A 2021 review of YK-11 pharmacology in Molecules noted androgenic activity and HPTA suppression as the primary concerns for human use.
Androgenic Side Effects
Because YK-11 is DHT-derived, users predisposed to male pattern baldness may notice accelerated hair thinning at higher doses. Mild acne is also reported, particularly on the back and shoulders. These effects are dose-dependent.
Joint Dryness
A frequently reported complaint is joint dryness in the knees, elbows, and shoulders. This is likely related to reduced estrogen activity from the absence of aromatisation. Many users address this by stacking YK-11 with MK-677, which increases GH and IGF-1 and provides a protective effect on connective tissue.
Liver Considerations
Some evidence suggests YK-11 may place mild stress on hepatic function, consistent with its steroidal structure. Periodic liver enzyme monitoring (ALT, AST) is prudent for anyone running YK-11 for 8 weeks. Avoid alcohol during any YK-11 cycle.
YK-11 vs RAD-140 vs LGD-4033 — Which SARM Wins in 2026?
| Factor | YK-11 | RAD-140 | LGD-4033 |
|---|---|---|---|
| Primary mechanism | AR partial agonist + myostatin inhibitor | AR full agonist (non-steroidal) | AR full agonist (non-steroidal) |
| Structure | Steroidal (DHT-derived) | Non-steroidal | Non-steroidal |
| Best use case | Breaking genetic ceiling; advanced mass | Lean muscle, strength, cutting | Bulking, maximum mass gain |
| Daily dosage | 5–15 mg | 10–20 mg | 5–10 mg |
| Cycle length | 6–8 weeks | 8–12 weeks | 8–12 weeks |
| Suppression level | High | Moderate–High | Moderate |
| PCT required? | Yes — always | Yes | Recommended |
| Best for | Advanced athletes, hard gainers | All-round lean gains | Bulking, first SARM cycle |
Does YK-11 Require PCT?
Yes — and this isn't a nuanced "maybe." YK-11's DHT-derived steroidal structure produces meaningful HPTA suppression at all effective doses. A 2022 review in Drug Discovery Today categorised YK-11 among the highest-suppression SARMs alongside S-23. The goal of PCT is to restart the HPTA — restoring natural testosterone, LH, and FSH to pre-cycle levels.
Recommended PCT Protocol After YK-11
- Nolvadex (Tamoxifen): 20 mg/day for 4 weeks — preferred option for most users
- Clomid (Clomiphene): 25 mg/day for 4 weeks — alternative for severe suppression
- Start date: 24–48 hours after the last YK-11 dose
- Blood work: Test testosterone, LH, and FSH before PCT begins and 4 weeks after PCT ends
- Support supplements: Zinc, vitamin D, ashwagandha, sleep optimisation during PCT
How Do You Stack YK-11 for Maximum Results?
Stacking YK-11 with complementary compounds amplifies results through independent biological pathways.
Stack 1 — YK-11 + MK-677 (Lean Mass + Recovery)
This is the most popular YK-11 stack among advanced athletes in Dubai. MK-677 (Ibutamoren) elevates growth hormone and IGF-1 through the ghrelin receptor — a completely separate pathway from androgen receptor modulation. An added benefit: MK-677's IGF-1 elevation helps counteract the joint dryness that YK-11 sometimes causes.
- YK-11: 10 mg/day (5 mg AM + 5 mg PM), weeks 1–8
- MK-677: 20–25 mg/day at night, weeks 1–12 (can continue through PCT)
- PCT: Begin 24–48 hours after final YK-11 dose; continue MK-677 through PCT
Stack 2 — YK-11 + LGD-4033 (Maximum Mass)
This stack combines YK-11's myostatin-inhibiting capability with LGD-4033's full androgen receptor agonism. For experienced users only — a full 6-week PCT is mandatory.
- YK-11: 10 mg/day, weeks 1–8
- LGD-4033: 5 mg/day, weeks 1–8
- PCT: 6-week Nolvadex protocol (20 mg/day weeks 1–2, 10 mg/day weeks 3–6)
Is YK-11 Legal in Dubai and the UAE?
YK-11 is not a licensed pharmaceutical in the UAE and does not appear in the UAE's list of controlled narcotic or psychotropic substances under Federal Law No. 14 of 1995. It circulates as a research chemical. WADA placed YK-11 on its Prohibited List under category S1.2 (Other Anabolic Agents) as of the 2022 update, meaning athletes in sanctioned sports risk disqualification if they test positive.
Frequently Asked Questions About YK-11 in the UAE
What makes YK-11 different from other SARMs?
YK-11 is the only SARM that inhibits myostatin by upregulating Follistatin in muscle cells, theoretically allowing muscle growth beyond the genetic ceiling. A 2013 study in Biological and Pharmaceutical Bulletin confirmed this dual mechanism — partial AR agonism plus Follistatin-mediated myostatin suppression — making it uniquely potent among all SARMs.
What is the recommended YK-11 dosage?
The standard YK-11 dosage is 5–15 mg/day, split into two doses to account for its 6–10 hour half-life. Beginners start at 5 mg/day for the first two weeks before increasing to 10 mg. Cycles should not exceed 8 weeks due to increasing suppression without proportional benefit.
Does YK-11 require PCT?
Yes — YK-11 is one of the most suppressive SARMs available, and PCT is always required. Its DHT-derived steroidal structure produces significant HPTA suppression even at 5 mg/day. A 4–6 week SERM protocol (Nolvadex 20 mg/day) starting 24–48 hours after the last dose is the minimum.
What results can I expect from a YK-11 cycle?
Most experienced users report 4–7 kg of lean, dry muscle over a 6–8 week YK-11 cycle with an optimised diet. Strength gains typically become apparent by week 2–3. Gains tend to be keepable because YK-11 doesn't cause estrogenic water retention.
Is YK-11 legal in Dubai and the UAE?
YK-11 is not a controlled narcotic under UAE Federal Law No. 14 of 1995 and is not a licensed pharmaceutical in the country. It's sold as a research chemical. WADA added YK-11 to its Prohibited List in 2022 under S1.2 (Other Anabolic Agents). Users are responsible for verifying regulations applicable to their specific situation.
Can YK-11 be stacked with MK-677?
Yes — YK-11 and MK-677 is one of the most effective mass-building stacks. YK-11 drives anabolism via the androgen receptor and myostatin inhibition; MK-677 elevates GH and IGF-1 through the ghrelin receptor. MK-677 also helps counter YK-11's joint dryness. Run YK-11 at 10 mg/day and MK-677 at 20–25 mg/day at night.
The Bottom Line on YK-11 for UAE Athletes
YK-11 occupies a unique position in the SARM landscape. Its dual mechanism — androgen receptor activation plus myostatin inhibition via Follistatin — sets it apart from every other compound in the class. For advanced athletes in Dubai who've maximised what conventional training and nutrition can deliver, it represents a genuinely different option rather than just a stronger version of an existing SARM.
The trade-off is clear. YK-11's steroidal backbone makes it more demanding to manage than non-steroidal SARMs like RAD-140 or Ostarine. Suppression is real and significant. PCT isn't suggested — it's required. If you haven't run a full cycle of LGD-4033 or RAD-140 and managed the recovery properly, start there first.
Shop YK-11 and SARMs — Delivered Across the UAE
Browse YK-11, RAD-140, LGD-4033, MK-677 and complete stacks. Fast delivery to Dubai, Abu Dhabi, Sharjah and across the GCC.
Shop SARMs Now
CoreSup stocks pharmaceutical-grade bacteriostatic water (10ml, 0.9% benzyl alcohol) with same-day delivery across Dubai and all UAE emirates.
Shop Bacteriostatic Water →Shop Featured Products
Related Products
Written by Amir Arsalan
Core Sup Research Team · Peptide & Supplement Specialists, Dubai UAE
Core Sup's editorial team is composed of specialists in peptide therapy, SARMs, and sports supplementation with direct experience in the UAE market. All content is written to current research standards and reviewed before publication.
Last reviewed: March 2026 · About Core Sup
